🔎 Trials Near Me

Home › Edema sa Macula › North Carolina

Pag-aaral pangklinika para sa Edema sa Macula sa North Carolina

6 pag-aaral para sa Edema sa Macula ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  • North Carolina Retina Associates, Wake Forest
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06962839

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  • North Carolina Retina Associates ( Site 0064), Wake Forest
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07705555

Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients

  • Duke Eye Center - Duke University Hospital, Durham
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT06395285

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

  • North Carolina Retina Associates (Cary), Cary
  • North Carolina Retina Associates (Wake Forest), Wake Forest
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06990399

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

  • North Carolina Retina Associates (Cary), Cary
  • North Carolina Retina Associates (Wake Forest), Wake Forest
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06996080

Imaging Retinal Vasculature in Infant Eyes

  • Duke University, Durham
Nagre-recruitObservasyonal na pag-aaral
2 Months · Lahat ng kasarian · Na-update Okt 6, 2025 · NCT05558059

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.